NeuPath Health Inc. (CVE:NPTH) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
The NeuPath Health Inc. (CVE:NPTH) share price has done very well over the last month, posting an excellent gain of 27%. Looking further back, the 11% rise over the last twelve months isn’t too bad notwithstanding the strength over the last 30 days.
Although its price has surged higher, when close to half the companies operating in Canada’s Healthcare industry have price-to-sales ratios (or “P/S”) above 1.1x, you may still consider NeuPath Health as an enticing stock to check out with its 0.2x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it’s justified.
View our latest analysis for NeuPath Health
